No translate

Nguyễn Thị Ái Vân; Nguyễn Thị Bạch Yến; Hoàng Thị Lâm

doi:10.58354/jvc.90.2019.1218

Home

NGHIÊN CỨU LÂM SÀNG Issue: Số 90, 2019 TIM MẠCH DỰ PHÒNG

No translate

Published: September 9, 2026

10.58354/jvc.90.2019.1218

Abstract

No translate

Keywords

No translate

References

1. J.Nossent,N.Cikes,E.Kiss,etal., Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual, Lupus 16 (5) (2007) 309–317.

DOI: doi.org/10.1177/0961203307077987

2. Calvo-Alen, S.M. Toloza, M. Fernandez, et al., Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for e occurrence of venous thrombosis in lupus patients, Arthritis & Rheumatism 52 (2005) 2060–2068.

DOI: doi.org/10.1002/art.21149

3. ĐỗThúyVân, luận văn thạc sỹ y khoa “nghiên cứu mối liên quan giữa tình trạng rối loạn lipid máu với mức độ hoạt động của bệnh lupus ban đỏ hệ thông” (2017) Trang 67-70.

4. SiricheepchaiyanW,NarongroeknawinP.,PakchotanonR.Etal. (2016). Lupus Damage and Waist Circumference as the Independent Risk Factors for Cardiovascular Disease in SLE Patients from Phramongkutklao Hospital. J Med Assoc Thai, 99(3), 290–300.

5. BalloccaF.,D’AscenzoF.,MorettiC.,etal.(2015). Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. EurJPrevCardiol, 22(11), 1435–1441.

DOI: doi.org/10.1177/2047487314546826

6. Bruce I.N., Urowitz M.B., Gladman D.D. et al. (2003). Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study: Coronary Risk Factors in Women with SLE. Arthritis & Rheumatism, 48(11), 3159–3167.

DOI: doi.org/10.1002/art.11296

7. HeC.,ShiW.,YeZ,etal.(2011). Cardiovascularrisk profileinsystemic lupus erythematosus: a cross-sectional study of 879 patients. Nan Fang Yi Ke Da Xue Xue Bao, 31(11), 1910–191.

8. MokC.,BirminghamD.J.,HoL.Y.,etal. (2013). High sensitivity C-reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematosus. ArthritisCareRes(Hoboken), 65(3), 441–447.

DOI: doi.org/10.1002/acr.21841

9. McMahonM.,HahnB.H.,andSkaggsB.J.(2011). Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. ExpertRevClinImmunol, 7(2), 227–241.

DOI: doi.org/10.1586/eci.10.98

10.

10. Roman M.J., Shanker B.-A., Davis A., et al. (2003). Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med, 349(25), 2399–2406.

DOI: doi.org/10.1056/nejmoa035471

Tác giả

Nguyễn Thị Ái Vân: Bệnh viện Đa khoa tỉnh Phú Thọ; Nguyễn Thị Bạch Yến: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai; Hoàng Thị Lâm: Trung tâm Dị ứng – Miễn dịch Lâm sàng, Bệnh viện Bạch Mai;